[Parkinson's disease and it's look-alike]

Area of Science:

• Neurology
• Neuroscience
• Medical Diagnostics

Background:

• Accurate diagnosis of Parkinson's disease (PD) necessitates excluding other neurological disorders.
• Clinical symptoms alone are often insufficient for differentiation, requiring drug response data and imaging.
• Distinguishing PD from progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) presents diagnostic challenges.

Purpose of the Study:

• To highlight the importance of systematic neurological examinations in differentiating Parkinson's disease from similar neurological conditions.
• To discuss the evolving landscape of diagnostic tools for Parkinson's disease and related disorders.
• To emphasize the continued relevance of clinical neurological assessments amidst technological advancements.

Main Methods:

• Review of recent findings on specific neurological signs and symptoms useful for differential diagnosis.
• Analysis of the role of clinical information, drug responses, and imaging in diagnosing Parkinson's disease.
• Discussion of emerging diagnostic technologies including imaging techniques and artificial intelligence.

Main Results:

• Specific neurological signs and symptoms aid in differentiating PD, PSP, and MSA.
• Drug response and imaging data supplement clinical evaluation.
• Imaging and AI-based diagnostic methods are under development.

Conclusions:

• Systematic neurological examinations are vital for diagnosing Parkinson's disease and related disorders.
• Despite advancements in imaging and AI, clinical expertise in neurological assessment remains indispensable.
• A comprehensive diagnostic approach integrating clinical, pharmacological, and imaging data is essential.